STUDIO

BioInvent and CASI on their collaboration

In a BioStock Studio exclusive, Martin Welschof, CEO of BioInvent and Wei-Wu He, Chairman and CEO of the American biopharma company CASI Pharmaceuticals, joined...

RECOMMENDED READING

BioMarin’s gene therapy treatment receives EU approval

The European Medicines Agency (EMA) has approved BioMarin's gene therapy for the treatment of...
Lipum

Lipum’s work with its Target Product Profile

Developing a so-called Target Product Profile is an important part of the drug development...

EVENT